To develop new challenge models (e.g. P. vivax, B. pertussis), improve methodology (study designs, simulation and mathematical modeling, biomarker development) and validate challenge models with real world data.
To use existing synergies to identify and close gaps in human capacity and infrastructure to further increase international visibility and to apply for external funding.
To establish and assess the program's governance models.